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The disparity between survival rates for Black and White women with breast cancer is 
well documented and has been examined in terms socioeconomics, environment, tumor 
type, and genetics.  However, there is little examination of the role of health care 
facilities in cancer disparities.  Health care facilities are representative of societal norms 
and beliefs that include location, quality of care, finance, policies, and staffing; therefore, 
they are a proxy for social justice and social change.  The purpose of this study was to 
examine correlations between health care facility type; social determinants of cancer such 
as poverty, culture, and social justice; and breast cancer survival rates.  Using the social 
determinants of cancer theoretical framework, the breast cancer survival rate of 4,087 
Black and White women in Georgia between the ages of 45 and 69 was studied.  The 
relationship between breast cancer survival and predictors including race, income, health 
care facility type, grade, and tumor type (4 sub-variables) were examined using the 
Kaplan-Meier Method, log-rank test, and Cox proportional hazard model. The log-rank 
test suggested no statistically significant difference in the survival functions among 
patients in different health care facilities (χ2(2) = 0.0150, p = 0.9926). The Cox 
proportional hazard model suggested no statistically significant relationship between 
breast cancer survival and health care facility type, after controlling for other predictors 
(χ2(2) = 0.3647, p = 0.8333).  This result indicates that healthcare facilities do not 
influence breast cancer survival rates, however given the persistent health outcome 
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Chapter 1: Introduction to the Study 
Of all the forms of inequality, injustice in health is the most shocking 
and the most inhuman because it often results in physical death 
—Martin Luther King, Jr., 1966 
In 2014, the Center for Reproductive Rights cited accounts of discrimination in 
the health care system, leading to adverse health outcomes.  However, when surveyed, 
most physicians have responded that their personal biases do not affect their ability to 
respond and treat patients of diverse backgrounds (Blair et al., 2014).  Despite these 
responses, data has indicated that physician bias is inversely related to quality of 
decisions regarding treatment and communication with Black patients, especially 
regarding diseases associated with minority patient groups (Moskowitz, Stone, & Childs, 
2012).   
Although the incidence rate in Georgia for female breast cancer for Black women 
is lower than White women, the estimated 5-year survival probability for White women is 
0.8648 compared to 0.7833 for Black women.  The difference in mortality rates is a 
significant health disparity (Hunt et al., 2013); however, it can be studied using the social 
determinants framework of Freeman and Chu (2005).  Three primary social 
determinants—poverty, culture, and social justice—influence early detection, diagnosis, 
treatment, posttreatment quality, and survival mortality of cancer.  Poverty leads to a lack 
of resources and information in addition to inadequate living conditions and risky 
behaviors, culture shapes people’s environments and perceptions and actions of their 
environments, and social justice dictates principles of equity and justice. Thus, these 
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three factors were investigated because they may influence disparities in breast cancer 
survival rates between Black and White women in Georgia. 
In this study, income was used as a proxy for poverty, race was a proxy for 
culture, and the hospital demographic of control/ownership type was the proxy for social 
justice.  Data were collected from the Georgia Center for Cancer Statistics, which is the 
Surveillance, Epidemiology, and End Results database for the state of Georgia, and the 
American Hospital Association.  Chapter 2 contains a review of the literature surrounding 
this topic.  The methods used to answer the research questions are outlined in Chapter 3. 
Background 
Researchers have suggested that since the establishment of the U.S. health care 
system in the 19th century, there have been conscious efforts to structure the system to be 
racially and socially separate (Feagin & Bennefield, 2014; Krieger, 2014; White, Haas, & 
Williams, 2012; Williams & Mohammed, 2013).  For example, prior to 1960, there was 
an institutional mandate that Blacks and Whites should receive care on separate floors 
(White et al., 2012).  The 1964 Civil Rights Act, Title IV was designed to end the 
practice of separate and unequal health care systems through the mandate of equal access 
for all races (Yearby, 2014).  But the remnants of institutionalized discrimination remain 
from decades of structural racism (Feagin & Bennefield, 2014; Krieger, 2014; Molina, 
Silva, & Rauscher, 2015; Viruell-Fuentes, Miranda, & Abdulrahim, 2012).  Despite legal 
assurances, the health care system has institutionalized policies that result in racial 
disparities due to unequal access for Blacks compared to Whites, resulting in racial 
disparities in health care.  For example, the ability of the American Medical Association 
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to control the market supply of physicians through profit maximization (Friedman, 1962; 
Kessel, 1958) or quality control among physicians (Arrow, 1963; Leffler, 1978) has been 
noted since the late 1950s.  These regressive policies have led to medically underserved 
areas, and racial inequalities have endured because of race-based socioeconomic 
differences (Phelan & Link, 1995).     
Overall, the health status of Americans has improved in recent years; however, 
racial inequities in the United States continue to persist (Akinboro et al., 2015; Anderson, 
2012; Chen & Li, 2015; Molina et al., 2015).  Racial inequity in the health care system 
violates principles of social justice (Rivera, 2014; Roux, 2012; Smedley & Myers, 2014) 
in addition to increasing the United State’s economic burden.  The United States 
currently spends $2.7 trillion on health care costs, which is an estimated 18% of U.S. 
gross domestic product (Moses et al., 2013).  Annually, the United States loses $200 
billion due to premature deaths related to racial health care disparities (Ayanian, 2015). 
The elimination of racial inequities in the health care system is one of the four key 
goals of Healthy People 2020 (U.S. Department of Health and Human Services, 2012).  
Recommendations and strategies to address racial inequities have been focused on the 
promotion of awareness of disparities in the public and medical sector (U.S. Department 
of Health and Human Services, 2012).  Despite the emphasis on awareness, the United 
States has been unable to eradicate racial inequalities in the health care system.  The 2014 
Agency for Healthcare Research and Quality, National Healthcare Quality and 
Disparities Report found that as of 2012, disparities in quality of care not only failed to 
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decrease but certain disparities, such as breast cancer among Black women, increased 
(U.S. Department of Health & Human Services, 2015).   
To address racial inequalities in health care, it is important to understand how 
systems are structured within the context of norms and policies.  The socioeconomic 
status paradigm has in many ways placed the burden to fix the system on those who have 
been disenfranchised by the health care system. Bronfenbrenner (1977) recognized in the 
model of social ecology that the relationship between individuals and their environmental 
system are interdependent.  Individuals do not typically act outside of their environment’s 
system and system constraints, and reciprocally, individuals are a reflection of the 
individuals that comprise the system.  In this context, the different levels and components 
(structures and institutions) of the system are a proxy for individual beliefs and norms.   
Previous studies have established that racism occurs on several levels of society 
(Feagin & Bennefield, 2014; Jones, 2002; Matthew, 2015).  Jones (2002) defined racism 
as 
A system of structuring opportunity and assigning value based on the social 
interpretation of how we look that unfairly disadvantages other individuals and 
communities and unfairly advantages other individuals and communities, and saps 
the strength of the whole society through the waste of human resource. (p. 9)  
Jones’s system-based definition of institutionalized racism is derived from the structures 
of a system such as policies and norms that sometimes prevent access based on race.  In 
contrast to institutionalized racism, structural racism is defined at system macro levels.  
Structural racism has been defined as racism that influences socioecological levels and 
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does not require the involvement or intent of individuals (Bonilla-Silva, 1997); it is self-
sustaining (Link & Phelan, 1995), and if individual and interpersonal discrimination were 
eliminated, the racial inequities resulting from structural racism would remain due to its 
self-sustaining nature (Jones, 2002).  Consequently, interventions that target individual 
awareness will have minimal impact on racial inequities resulting from structural racism.  
Therefore, there needs to be a paradigm shift from an examination of individuals to an 
examination of the health care system in terms of delivery and quality of care to address 
racial inequalities  (Baron et al., 2014; Feagin & Bennefield, 2014; Jones, 2002; Wheeler, 
Reeder-Hayes, & Carey, 2013).   
Several studies since 2010 have addressed the awareness of racial inequities in the 
medical community with the purpose of assessing individual belief paradigms (Greysen 
et al., 2011; Haider et al., 2015; Medina-Walpole, Mooney, Lyness, Lambert, & Lurie, 
2012; Paradies, Troung, & Priest, 2014; People, 2013; Roux, 2012; Williams & 
Mohammed, 2013).  However, there is a need for research on the relationships between 
system-level issues and their impact on addressing timeliness in detection (Molina et al., 
2015); the impact of multisystem, multifactorial approaches (Chen & Li, 2015); and the 
influence of institutionalized policy on the distribution of and access to health resources 
(Smedley & Myers, 2014). 
Addressing issues with the health care system is especially important to examine 
the disparities in mortality rates between Black and White women.  For example, the 
disparate breast cancer mortality outcomes for Black women have been well documented 
(Chen & Li, 2015; Molina et al., 2015; Tatalovich et al., 2015).  Studies on the 
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relationship between social determinants and disparate breast cancer mortality outcomes 
for Black women suggest that economic and social barriers are related to Black women 
breast cancer outcomes (Januszewski, Tanna, & Stebbing, 2014; Reeder-Hayes, Wheeler, 
& Mayer, 2015; Wheeler et al., 2013).  The difference in mortality rates is notable 
because White women are more frequently diagnosed with breast cancer (Siegal, Miller, 
& Jamal, 2015).  Despite research and interventions in addressing these differences in 
mortality rates, it remains an issue.  Researchers need to examine outcomes determined 
by interactions within the health system, particularly the points of service represented by 
health care facilities, because of the disparity between treatments and outcomes 
(Carpenter et al., 2011; Wheeler et al., 2012a, 2012b, 2013). 
Problem Statement 
Breast cancer is currently the most common form of cancer diagnosed among 
women in the United States, with 1 in 3 cancers attributable to breast cancer (DeSantis, 
Ma, Bryan, & Jemal, 2014).  The estimated 2013 incidence was 296,980 new cases of 
breast cancer and 39,620 related deaths (DeSantis et al., 2014).  The incidence rate from 
2006–2010 of female breast cancer per 100,000 women in Georgia was 124.0 for White 
women and 120.9 for Black women (DeSantis et al., 2014).  However, during the same 
period, the death rate per 100,000 of White females was 21.9, while the death rate of 
Black females was 29.6 (DeSantis et al., 2014).  Although the incidence rate for female 
breast cancer for Black women is lower than White women, the estimated 5-year survival 
probability for White woman is 0.8648 compared to 0.7833 for Black women (DeSantis 
et al., 2014).   
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It was not until the early 1970s that surveillance of breast cancer was 
institutionalized (Yamauchi et al., 2012), which brought more awareness to the 
differences in breast cancer rates based on race.  For instance, White, Daling, Norsted, 
and Chu (1987) conducted a study that revealed a higher incidence of breast cancer in 
Black women (as cited in Krieger, 1988), though their concern was with an increased 
incidence of breast cancer in women’s decision to delay childbearing.  In recent years, the 
reason for the higher mortality rate of Black women has been examined to determine 
cause (Hunt et al., 2013).  For example, Chen and Li (2015) examined treatment 
variations based on type of breast cancer and found that certain racial and ethnic groups 
were behind Whites in receiving early diagnosis and recommended treatments.  Racial 
disparities in breast cancer mortality may exist due to Black women’s lower access to 
preventive screenings and treatment and lower quality care due to issues like comorbid 
diseases, provider–patient miscommunication, and mistrust (Hunt et al., 2013).  
Additionally, there might be a link between the health care facility and social 
determinants such as median household income, racial segregation, and financial 
inequality that leads to discontinuity in breast care evaluation and treatment (Daly & 
Olopade, 2015; Hunt et al., 2013).  Regardless of why, the racial disparity in care affects 
health outcomes and survival rates (Daly & Olopade, 2015).   
Though there is attention on genetic solutions to the disparity in breast cancer 
mortality, equal access to quality early detection and treatment can address the racial 
disparities in mortality rates (Hunt et al., 2013).  Higher rates of late stage breast cancer 
are more probable in areas with predominant Black populations where screening 
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availability is low (Tatalovich et al., 2015).  In addition, previous research has been 
focused on patient-level factors but less is known about what role health care facilities 
play in breast cancer care (Molina et al., 2015).  Therefore, this study was conducted to 
address the problem of racially disparate mortality rates and determine how type of health 
care facility and social determinants such as median household income, racial 
segregation, and financial inequality affect breast cancer care. 
Purpose Statement 
The purpose of this quantitative study was to determine if the social determinants 
of poverty, culture, and social justice factors outlined in the health inequalities framework 
correlate to the breast cancer survival rate of Black and White women in Georgia.  Data 
were collected from the Surveillance, Epidemiology, End Results national cancer 
database, the Georgia Center for Cancer Statistics, and the American Hospital 
Association.  The data were analyzed using Kaplan Meir method, log-rank tests, and Cox 
proportional hazards model (see Kleinbaum & Klein, 2012) to examine the relationship 
between the breast cancer survival rate of Black and White women in Georgia and the 
predictors of race, income, health care facility type, grade, and tumor type. 
Research Questions 
The following research question was designed to guide this study: Do poverty, 
culture, and social justice affect the breast cancer survival rate of Black and White 
women in Georgia? The following are research questions and hypotheses based on 
answering this central question: 
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Research Question 1: Is poverty (income) a determinant of the breast cancer 
survival rate of Black and White women in Georgia? 
H01: Poverty is not a determinant of the breast cancer survival rate of Black 
and White women in Georgia. 
Ha1: Poverty is a determinant of the breast cancer survival rate of Black and 
White women in Georgia. 
Research Question 2: Is culture (race) a determinant of the breast cancer survival 
rate of Black and White women in Georgia? 
H02: Culture is not a determinant of the breast cancer survival rate of Black 
and White women in Georgia. 
Ha2: Culture is a determinant of the breast cancer survival rate of Black and 
White women in Georgia. 
Research Question 3: Is social justice (type of health care facility) a determinant 
of the breast cancer survival rate of Black and White women in Georgia? 
H03: Social justice is not a determinant of the breast cancer survival rate of 
Black and White women in Georgia. 
Ha3: Social justice is a determinant of the breast cancer survival rate of Black 
and White women in Georgia. 
Research Question 4: What is the relationship between poverty, culture, and 
social justice as a determinant of the breast cancer survival rate of Black and 
White women in Georgia? 
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H04: None of the independent variables (poverty, culture, and social justice) 
have a statistically significant relationship on breast cancer survival rates of 
Black and White women in Georgia. 
Ha4: The independent variables (poverty, culture, and social justice) have a 
statistically significant relationship on breast cancer survival rates of Black 
and White women in Georgia. 
Theoretical Framework 
The theoretical framework for the study was the social determinants of health 
inequalities framework as outlined by Marmot (2005).  However, the cancer-related 
social determinants framework as described by Freeman and Chu (2005) was also 
applied.  In general, the social determinants of health correlate disease to social settings.  
In the context of cancer outcomes, the social determinants of poverty, culture, and social 
justice influence early detection, diagnosis, treatment, posttreatment quality, and survival 
rates.  For example, poverty leads to a lack of resources and information (Freeman & 
Chu, 2005).  In the study, income was a proxy for poverty.  In addition, culture, which 
can be defined as behavior that has been developed and passed on through generations 
(Mead, 1963) as well as the knowledge and behavior shared by a group (Peoples & Baily, 
2012), was determined in this study by race.  Finally, social justice can be defined as a 
point in time when societal power allows for the distribution of outcomes that does not 
result in an exploiter or victim (Walster et al., 1975). In this study, the type of a health 
care facility was the proxy for social justice.  These three factors were investigated 
regarding disparities in breast cancer survival rates between Black and White women. 
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There is a need to address established health disparities through health inequities 
rooted in social issues (culture), poverty (economics), and the direct effect of structural 
racism (social justice; Rice, Nadig, Simpson, Ford, & Goodwin, 2014).  It is through 
these mechanisms that health inequities exist.  However, several studies on racial 
discrimination in health care include the perspective that Blacks’ genetic predisposition 
(Dietze, Sistrunk, Miranda-Carboni, O’Regan, & Seewaldt, 2015), personal choices 
(Slattery et al., 2014), or personal responsibility (Geers et al., 2013; Newson et al., 2013; 
Voigt, 2013) results in a higher disease rate than Whites.  Key examples of these 
perspectives can be found in breast cancer research (Anderson, Mackison, Boath, & 
Steele, 2013; Paxton, Taylor, Chang, Courneya, & Jones, 2013; Weber, Solomon, & 
Meyer, 2013).  This assumes the concept of risk and does not examine the role of 
structural or institutionalized discrimination in increasing the disease incidence or 
mortality rate.  Therefore, this study was conducted to examine how poverty (income), 
culture (race), and social justice (type of health care facility) affect cancer rates among 
White and Black women. 
Nature of Study 
My study is quantitative and involved a retrospective cohort design to study 
similarly situated groups that differ by a specific characteristic (see Downing et al., 
2014). Using a retrospective cohort design, I examined common exposure factors such as 
health care facility type, income, and race to determine their influence on survival 
outcomes between Black and White women.  This study design is consistent with the 
collection and analysis of numerical data collection based on mathematical methods to 
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prove or disprove a hypothesis (see Creswell, 2013).  The traditional realist worldview 
advocates that the quantitative approach is used to uncover truth using objective research 
and methods of analysis (Creswell, 2013).  This approach allowed for the objective 
examination of the controversial issues of race and health 
Definitions 
Health care facility: The study includes three ways of defining health care 
facilities: 
• For-profit: Health care facilities that are not barred from distributing profits, 
typically privately owned   
• Nonprofit: Health care facilities barred from distributing profits 
• Government: Health care facility owned by a government entity (Bjorvatn, 
2018). 
Poverty: The official definition of poverty is based on economic guidelines 
established by the U.S. Department of Health & Human Services.  For example, a family 
of three with a total income of $20,160 is considered to be living in poverty (Federal 
Register, 2016).  
Social justice: There are two commonly accepted definitions of social justice.  
Rawls (2009) advocated that in an environment of scare resources and competing 
interests, people will choose to advance those interests on mutually acceptable terms and 
if people are kept ignorant regarding their position, then principles of justice will be 
chosen that are fair to all.  This definition is sometimes referred to as noncomparative 
social justice.  In contrast, Miller (1979) suggested a more pluralist approach: justice is 
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given through the considered relationship between the people involved.  This perspective 
is often referred to as comparative social justice.  It is this definition that Freeman and 
Chu (2005) adopted in the social determinants framework to address inequities in health 
care delivery and access particularly related to cancer, which was used in this study.   
Assumptions, Limitations, and Delimitation 
The study assumed that the data from the Georgia Cancer Registry and the 
American Hospital Association would provide definitive, up-to-date information to 
answer the research questions.  
The limitations for the study are that the data used to analyze the research 
questions were collected from the Georgia Cancer Registry, which only collects data for 
one state.  Therefore, the findings cannot be generalized nationally.  Additionally, the 
quantitative results of the study can only demonstrate correlation and not causation. 
Finally, a delimitation of this study was the breadth.  The study was limited to 
health care facilities in Georgia and Black and White women in Georgia diagnosed with 
breast cancer.  Data were downloaded from the Georgia Cancer Registry and the 
American Hospital Association.  This study was only conducted to determine if there is a 
correlation between the three social determinants of poverty, culture, and social justice.  
No causal nature of any identified relationship would be able to be determined, though 
the study provides preliminary data that can serve as a foundation for further research that 




It is well documented that disparities exist for Black women regarding the 
prevention, diagnosis, and treatment of breast cancer (Chen & Li, 2015).  If accessing a 
type of health care facility is positively or negatively associated with survival rates, the 
information derived from the study may provide information to patients and providers to 
make an educated choice regarding prevention and treatment.  Findings from the study 
may also help health care facilities improve the way they work with patients, which can 
lead to improved health outcomes. 
Social Change 
Scientific pursuit sometimes needs to involve pieces of knowledge rather than 
cumulative knowledge (Kuhn, 2012), which represents this study’s purpose of providing 
knowledge on disparities in mortality rates between White and Black women.  In my 
study, I examined the effect of health care facilities on health outcomes, going beyond the 
variables of race, gender, and income that are commonly investigated.  My approach 
addresses the core of public health policy—social justice.  Social justice demands that 
public health address disparities based on health inequities to eliminate health disparities.  
Rather than claiming that Black women have higher mortality rates from breast cancer 
because they are Black and may have a lower socioeconomic status, “The causes of the 
causes” (p. 1101) need to be addressed (Marmot, 2005, p. 1101).  Examining the 
institutions through which Black women receive preventative care, screening, diagnosis, 
and treatment is central to understanding how being Black with lower socioeconomic 
status influences their care in the current health care system.   
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Health care facilities are representative of societal norms and beliefs that include 
location, quality of care, finance, policies, and staffing; therefore, they can be used as a 
proxy for social justice.  In this study, I sought to understand the role of health care 
facilities in disparate health outcomes.  As illustrated by Frieden’s (2010) health impact 
pyramid, addressing structural issues of socioeconomic disparities through policy will 
lead to lasting societal changes resulting in improved health outcomes.  Therefore, this 
study may lead to social change through findings highlighting the effect of health care 
facilities on breast cancer mortality rates between Black and White women. 
Summary 
Although the incidence rate in Georgia for female breast cancer for Black women 
is lower than White women, the estimated 5-year survival probability for White women is 
0.8648 compared to 0.7833 for Black women.  Thus, the difference in mortality rates is a 
significant health disparity (Hunt et al., 2013).  In this study, this health disparity was 
studied using the social determinants framework of Freeman and Chu (2005) with three 
primary social determinants: poverty, culture, and social justice, which can affect early 
detection, diagnosis, treatment, posttreatment quality, and survival mortality of cancer.  
Poverty leads to a lack of resources and information, resulting in inadequate living 
conditions and risky behaviors.  Shared culture and the consequent transfer of knowledge 
and customs can further enhance or diminish the influence of poverty.  Finally, social 
justice is reflected in the resources brought to the community through the health care 
facility. Thus, these three factors that can influence disparities in breast cancer survival 
rates between Black and White women in Georgia were investigated. In the study, 
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income was used as a proxy for poverty, race was a proxy for culture, and type of health 
care facility was the proxy for social justice.  Data were collected from the Georgia 
Center for Cancer Statistics and the American Hospital Association.  Chapter 2 contains a 
review of the literature surrounding this topic.
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Chapter 2: Literature Review 
The function of this literature review is to provide an overview of the literature 
pertaining to health care facilities as a predictor of breast cancer mortality rates.  The 
literature review includes the theoretical foundation for the study and a review and 
synthesis of literature relevant to key concepts of the study.  Currently breast cancer is the 
most common form of cancer for women in the United States (DeSantis et al., 2014).  In 
Georgia, the 2013 incidence rate for female breast cancer per 100,000 women was 124.00 
for White women and 120.4 for Black women, yet the mortality rate (per 100,000) during 
the same period for White women was 21.9 and 29.6 for Black women (DeSantis et al., 
2014).  This health disparity is significant (Hunt et al., 2013) and has been confirmed in 
peer-reviewed literature, though studies have been limited to the socioeconomics of the 
affected women.  Although studies mention institutional factors, no studies were found 
that identified specific institutional causes.   
Literature Search Strategy 
PubMed (inclusive of Medline and CINHAL) was used online to locate peer-
reviewed literature.  The following search terms were used: African American women, 
Black women, breast cancer, health care facilities, mammogram, access to health care, 
socioeconomic status, survival, screening, neighborhood, access, hospital ownership 
type, and breast cancer.  The initial keyword searches resulted in 1,286 records.  
Abstracts were scanned and duplicates were removed resulting in 987 articles.    
Backward and forward snowballing was conducted to identify new papers not included in 
the original set.  This process was continued until no new relevant papers could be found.  
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Papers were reviewed for either exclusion or inclusion.  The full text review for relevance 
resulted in a total of 987 articles.  A total of 138 articles were included in the study. 
Theoretical Foundation 
In this study, I applied the social determinants of health and the determinants of 
cancer disparities (see Freeman & Chu, 2005).  Whereas the social determinants of health 
delineate factors that affect health (World Health  Organization, 2016), the social 
determinants of health inequalities involve social factors that lead to health inequalities 
(Marmot, 2005).  These determinants include conditions in which people live and work, 
and include economic stability, availability of health care, social and community context, 
and education (U.S. Department of Health and Human Services, 2012).  The social 
determinants of health inequalities include the triad of health systems, poverty/inequality, 
and social determinants (Marmot, 2005).  The underlying premise is that poverty and 
inequality in all its forms can be material in its impact on health outcomes.  Health 
system and social determinant interventions that do not address material resources 
(poverty) and who receives the resources (inequality) will fail to address the causes of the 
causes of health disparities (Marmot, 2005).   
Freeman and Chu (2005) further refined the determinants of health inequalities 
with their focus on the social determinants of cancer disparities.  They suggested that 
there is a lack of relationship between the medical advances (discoveries) made in cancer 
and the delivery (inequality), leading to a disparity in the health outcomes of cancer 
(Freeman & Chu, 2005).  Freeman and Chu presented a three-pronged approach to 
understanding this lack of relationship: culture, poverty, and social injustice.  Poverty can 
19 
 
manifest as a “lack of resources, inadequate information and knowledge, substandard 
living conditions, risk-promoting lifestyles, attitudes, behaviors, diminished access to 
health care, and poor nutrition” (Freeman & Chu, 2005, p. 656).  Culture includes “an 
individual’s or community’s shared communication system, similarities in physical and 
social environments, common beliefs, values, traditions, and world view, and similarities 
in lifestyle, attitude, perceptions, and behavior” (Freeman & Chu, 2005, p. 656).  Finally, 
social justice consists of racial discrimination that limits equal access to health care for 
some populations (Freeman & Chu, 2005, p. 656).  It is through this perspective 
regarding these determinants that I viewed the impact of social determinants on 
prevention, screening, diagnosis, treatment, and rehabilitation regarding cancer. 
Though science and medicine use race as a proxy for culture, poverty, 
socioeconomics, and behaviors, race within Freeman and Chu’s (2005) paradigm 
becomes a separate social construct.  Freeman and Chu proposed that there a meaningful 
difference between culture and race.  Race as a social construct has no scientific or 
medical meaning, but rather a means developed by the Office of Management of the 
Budget to monitor and enforce civil rights laws.  Freeman and Chu stated that racial 
categories represent a way to collect data on race and ethnicity for populations but are not 
anthropologically or scientifically based (p. 664).  In medicine, race has been 
demonstrated to lead to disparate prevention, treatment, distribution of care, and false 
provider assumptions resulting in racial profiling (Nelson, 2002; Silber et al., 2013).  




Similar to Freeman and Chu (2005), in this study, I sought to move beyond race 
as a proxy for understanding racial disparities in mortality rates among Black women 
with breast cancer.  This has been supported in other research; for example, Zonderman 
et al. (2014) used the Freeman and Chu concept of social determinants of cancer 
disparities as a premise to develop a genetics-based framework that employed poverty 
rather than race as a premise.  By doing so, Zonderman et al. recognized that poverty 
results in conditions correlated with health disparities more often than race.  Furthermore, 
a study conducted by Roman et al. (2014) showed an expanded understanding of poverty, 
culture, and social justice.  Although Roman et al. used concepts of race to categorize 
their results, their findings of health literacy and physician recommendations cut across 
race.  Additionally, Gerand and Pai (2008) explicated the Freeman and Chu conceptual 
framework by describing specific barriers related to poverty, culture, and social justice: 
lack of primary care, geographical, physical access to care, comorbidities, health 
insurance, system level factors such as screening services, medical mistrust, and racism.  
This supports Freeman and Chu’s premise that barriers are related to poverty, culture, and 
social justice. 
With the guidance of Freeman and Chu’s (2005) framework, I examined 
associations between characteristics of health care facilities and the survival rates of 
Black women and White women.  Health care facilities are institutions that provide 
health care services to patients.  An institution is an entity with an accepted system of 
practices that creates shared constructs and confers a hierarchy so that those at a higher 
status can perform functions than those at a lower status, thought there is collective 
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intentionality (Searle, 2005).  As early as 1972, medicine was recognized as a social 
institution that makes collective judgements in the name of health.  Ownership or control 
of hospital services is a proxy of institutionalized medicine, as a social institution in the 
health care system embodies the institutionalized practices, policies, and procedures of 
institutionalized medicine (Bjorvatn, 2018, Eskoz & Peddecord, 1985; Sloan et al., 2001).  
Though racial constructs are often used in medicine and science to describe the social 
phenomenon of poverty, culture, and social justice, the Freeman and Chu conceptual 
framework allows for defining more precise variables that can affect the cancer 
continuum.   
Disparate Breast Cancer Outcomes 
Despite advances in medical research, interventions, and outreach, disparities in 
breast cancer mortality rates continue to exist among Black and White women in the 
United States (Veluswamy, Kinberg, & Bickell, 2013).  As of 2015, 231,840 new cases 
of breast cancer were diagnosed, and it is estimated that 40,290 deaths will result from 
these new cases (DeSantis et al., 2016).  Additionally, (a) breast cancer incidence rates 
increased for Black women, and (b) the mortality rate gap increased between Black and 
White women (DeSantis et al., 2016).  As of 2013 breast cancer incidence rate for Black 
women was less than for White women, but the mortality rate for Black women rose to 
42% while the mortality rate for White women remained flat compared to previous years 
(DeSantis et al., 2016).  In Georgia, the incidence ratio between Black and White women 
was .99 or no meaningful difference in incidence rates of breast cancer between Black 
and White women.  However, the mortality rate for White women in Georgia between 
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2008 and 2012 was 21.2 per 100,000 women (DeSantis et al., 2016).  The mortality rate 
for Black women in Georgia between 2008 and 2012 was 29.5 per 100,000 women 
(DeSantis et al., 2016).  Black women in Georgia were almost 40% times more likely to 
die from breast cancer than White women in Georgia.   
Tumor Type 
For over ten years, it has been a part of routine care to test for markers of breast 
cancer (Anderson, Rosenberg, & Katki, 2014), yet racial disparities in breast cancer 
continue to exist (DeSantis et al., 2016; Wheeler et al., 2013).  Black women in the 
United States comprise the most significant proportion of women diagnosed with HR-
/HER2- (triple negative) breast cancer, whereas White women in the United States 
comprise the most significant proportion of women diagnosed with the most responsive 
form of breast cancer, HR+/HER2- (DeSantis et al., 2016).   
Although there are 21 histologic types of breast cancer, only four are molecular 
types of breast cancer (DeSantis et al., 2016).  The molecular types are based on the 
expression of two receptors: the hormone receptor and the human growth factor-neu 
receptor (HER2; Howlader et al., 2014; Kohler et al., 2015).  Breast cancer type 
HR+/HER2+ has proteins that promote cancer cells and can be treated with hormone 
therapies.  However, Type HR+/HER2- is the most common.  It can also be treated with 
hormones but does not contain the protein that promotes cancer cells.   
Type HR-/HER2+ is commonly referred to as inflammatory breast cancer and 
contains invasive ductal carcinoma.  This form tends to be diagnosed at more advanced 
stages.  This type does not respond to hormone therapy and contains the protein that 
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promotes growth.  HR-/HER2- is also known as triple negative breast cancer.  It is 
negative for progesterone and estrogen receptors, so it is not receptive to hormone 
therapy and does not contain growth-promoting proteins.  Therefore, it is aggressive and 
often requires a combination of therapies that can include surgery, radiation, and 
chemotherapy (Howlader et al., 2014; Kohler et al., 2015).  The fact that Black women 
make up a large proportion of those who are diagnosed with this type of cancer may be 
why the mortality rates are higher; however, research has not addressed this racial 
disparity. 
The Role of Socioeconomics in Breast Cancer Racial Disparities 
Socioeconomics play a significant role in observed breast cancer racial disparities 
(Wheeler et al., 2013).  When biologic and clinical factors such as tumor type, hormone 
receptor, proficiency of prognosis, stage of diagnosis, and insurance are controlled, racial 
disparities are statistically significant (Wheeler et al., 2013).  For example, Feinglass et 
al. (2015) examined statistical relationships between socioeconomics and all-cause 
mortality among women with breast cancer.  Insurance coverage, race or ethnicity, stage 
of cancer, treatment modalities, personal demographics, and hospital type were controlled 
to determine impact.  Data from 582,000 female patients between 1988 and 2006 were 
obtained from the National Cancer Data Base and included follow-up through 2011 on 
vital status (Feinglass et al., 2015).  The sample included breast cancer patients from 
1,630 hospitals that reported to the National Cancer Database.  Patients’ ages were 
categorized as 39 and under, 40 to 49, 50 to 69, and 70 and older.  Race and ethnicity 
were categorized as non-Hispanic White, non-Hispanic Black, Hispanic, Asian, and other 
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or unknown.  The TNM (tumor, node, metastasis) classification of malignant tumors was 
used to classify stage.  Treatment included primary surgery (lumpectomy, mastectomy, or 
no or unknown surgery) and radiation, therapy, chemotherapy, and hormone therapy.  
Treating hospitals included large urban, medium urban, small urban, rural, unknown and 
academic, research, or community institutions (Feinglass et al., 2015).  
To control for trends in treatment, three periods were included: 1998‒2000, 2001‒
2003, and 2004‒2006 (Feinglass et al., 2015).  Hazard ratios were ranked for 16 
combinations of income, education, and zip code.  Zip codes were used as a proxy for 
socioeconomic status, resulting in a six-level measure for socioeconomic status, which 
was then grouped into five socioeconomic status categories ranging from highest income 
and education to lowest income and education (Feinglass et al., 2015).  A final category 
included patients without insurance or Medicaid coverage (Feinglass et al., 2015).  
Hierarchal Cox, proportional hazards analysis, was used to test the significance of the 
socioeconomic variables when controlling for patient and hospital variables (Feinglass et 
al., 2015).   
Feinglass et al. (2015) found that the 5-year survival rate for the highest 
socioeconomic status was 87.8% and 71.5% for the 10-year survival rate with a hazard 
ratio of 1.69.  The lowest socioeconomic status had a 5-year survival rate of 79.5% and a 
10-year survival rate of 61.5% with a hazard ratio of 1.27 (Feinglass et al., 2015).  When 
comorbidities and invasive cancer types were included in the model, the results remained 
the same (Feinglass et al., 2015).  Results showed that insurance status, cancer stage, and 
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race were essential components of socioeconomic status but only explained two-thirds of 
survival disparities (Feinglass et al., 2015). 
A limitation of the Feinglass et al. (2015) study was that it examined all-cause 
mortality rather than cancer-specific mortality.  Of note was that this significant study 
examined treatment modalities, hospital types, and socioeconomic status with mortality 
related to breast cancer.  Results showed a hazard ratio of 1.04 in medium urban region 
hospitals and .92 for rural region hospitals when compared to large urban region hospitals 
(Feinglass et al., 2015).  More significant were the treatment modalities.  Radiation 
therapy had a hazard ratio of .76 when compared to no radiation (Feinglass et al., 2015).  
Chemotherapy had a hazard ratio of .87 when compared to no chemotherapy (Feinglass et 
al., 2015).  Hormone therapy had a hazard ratio of .72 and receipt of no surgical 
interventions had a hazard ratio of 1.80 when compared to mastectomies (Feinglass et al., 
2015).  In addition to correlating socioeconomic status and mortality, the study 
demonstrated a correlation between hospitals (a type of health care facility), treatment 
type, and mortality.   
The Role of the Health care System in Breast Cancer Racial Disparities 
As recently as 2016, the Office of Civil Rights and Health and Human Services 
clarifying previous rulings by stating that, “Discrimination on the basis of race, color, 
national origin, sex, age, or disability” in health programs is prohibited (Federal Register, 
2016).  Yet discrimination in health care facilities and among health care professionals is 
well documented and has been litigated since the establishment of the United States 
health care system (Yearby, 2014).  Yearby (2015) explored how the health care system 
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has been affected by racial bias implemented through structural racism, institutional 
racism, and interpersonal racism.  Yearby cited Jones in defining racial bias as  
A system of structuring opportunity and assigning value based on the social 
interpretation of how we look (which is what we call ‘race’), that unfairly 
disadvantages some individuals and communities, and saps the strength of the 
whole society through the waste of human resources. (Yearby, 2015, p. 3)   
Racial bias has led to a government-sponsored separate and unequal health care 
system (Yearby, 2015).  The health care system maintained separate and unequal health 
care systems at the societal (structural) level through the establishment of an ability to 
pay system that provided a lesser quality of care to those who could not pay (Yearby, 
2015).  Social biases were augmented through organizational (institutional) structures 
that prescribed racial biases through policy by exempting physicians and by extension 
their health care facilities from requirements of Title VI (Yearby, 2015).  If Black 
patients are able to overcome structural and institutional barriers to health care, they are 
likely to encounter physicians’ (interpersonal) implicit and explicit biases that have 
resulted in Black patients either being denied cared, delayed care, or provided less than 
recommended care (Yearby, 2015).   
Health care Facilities as Barriers to Care 
Despite the abundant number of studies addressing health disparities and 
inequities in health care, structural forms of discrimination and their effect on health care 
delivery continues to be understudied (Krieger, 2012; Molina et al., 2015; Viruell-
Fuentes et al., 2012). Racism influences lives through segregation (Cozier et al., 2014), 
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education (Wheeler, 2015), employment (Wiecek & Hamilton, 2013), and health (Phelan 
& Link, 2015).  There is a need to shift the focus of study from individual causes 
(biology and culture) to societal level causes (racism) and how they affect the institutions 
that deliver care (Gee & Ford, 2011).  
A 2018 Norwegian study of hospital performance related to hospital ownership 
found that hospital ownership significantly impacted emergency services, specialization, 
selection of patients and quality of care (Bjorvatn, 2018).  Private hospitals compared 
other ownership types had reduced emergency services due to cost, increased more 
profitable specialization offerings, are slightly more likely to treat patients with more co-
morbidities, have shorter waits, shorter stays and have more elective admissions 
(Bjorvatn, 2018).  This study was particularly impressive.  Although the results were 
mixed, it did provide a prospective different ownership types while controlling for race 
(cultural differences) due to the relative heterogeneity of the Norwegian population.   
Institutional Racism: Medically Underserved Areas 
Massey and Denton (1993) stated that “Racial/ethnic segregation refers to the 
degree to which two or more groups live separately from one another in a geographic 
area.”  Racial residential segregation results from a combination of socioeconomic 
drivers: (a) education, income, and wealth, which can either increase or limit access to 
neighborhoods with resources; (b) racial and ethnic differences based on individual 
preferences to live among what is culturally identifiable; and (c) stratification resulting 
from White aversion to living with minority groups; thereby reinforcing discriminatory 
practices in housing (Crowder & Krysan, 2016).  Whatever the driver, primary 
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segregation rates between White and Black populations persistently remain high, leading 
to inequitable neighborhood resources (Crowder & Krysan, 2016).  Limited educational 
and employment opportunities resulting from residential segregation creates pockets of 
poverty that can limit access to health care resources (Butler, Petterson, Phillips, & 
Bazemore, 2013).  Less advantaged segregated neighborhoods are challenged 
economically and socially to attract and retain qualified physicians and create medically 
underserved areas (Rice, Nadig, Simpson, Ford, & Goodwin, 2014).  Medically 
underserved areas have been used the federal health agencies categorize areas of need 
according to the physician to population ratios based on poverty and mortality rates (Rice 
et al., 2014). 
Historically, within the broader context of racial segregation, segregation has 
played a significant role in the establishment and allocation of health care resources, 
specifically health care facilities (Ko, Needleman, Derose, Laugesen, & Ponce, 2014; 
Yearby, 2014).  Examples of health care facility segregation, reflecting the cancer 
continuum and based on location continue to be reported in geographic access to 
preventative screenings such as mammograms (Khan-Gates, Ersek, Eberth, Adams, & 
Pruitt, 2015), availability of breast cancer surgeons (Freedman, Kouri, West, & Keating, 
2015), timely receipt of adjuvant therapy (surgery followed by chemotherapy) 
(Freedman, He, Winer, & Keating, 2013), receipt of radiation therapy (Feinstein et al., 
2013), geographic variations in health care spending (Newhouse & Garber, 2013) and 
access to health care resources (Akinyemiju et al., 2013) despite the enactment of Title 
VI which was enacted to prevent racial discrimination in health care (Yearby, 2014).   
29 
 
Structural Discrimination: Discriminatory Policies and Practices 
Federal and state policies and practices have aided in the maintenance of separate 
and unequal health care system (Yearby, 2015).  This has been achieved through medical 
redlining (Beyer et al., 2016; Yearby, 2014; Yearby, 2015) or economic credentialing, the 
practice of rating physicians using economic criteria unrelated to quality or qualifications 
(Byrd & Clayton, 2012; Chakravarty, 2015; Rauch et al., 2012), excessive wait times for 
screening, diagnosis, and treatment (Bleicher et al., 2015; Downing, Twelves, Forman, 
Lawrence, & Gilthorpe, 2014; Hamel et al., 2014; Nolan et al., 2014), insurance coverage 
or the ability to pay in advance for access to health care (Gorey et al., 2013; Gorey et al., 
2015; Haji-Jama, Gorey, Luginaah, Balagurusamy, & Hamm, 2013), lack of continuity of 
care (Nolan et al., 2014; Weinstein, LaNoue, Hurley, Sifri, & Myers, 2015).   
America’s piecemeal approach to addressing health care disparities in race, 
gender, class, and region, has resulted in separate and unequal access in the delivery of 
health care (Hoffman, 2012).  Hospital policies of refusing to admit patients without a 
physician with admitting privileges served to restrict access further. (Casalino, 2013; 
Powers, Oriol, & Jain, 2015; Rosenbaum & Sager, 2015).  The Hill-Burton Act prevented 
discrimination in health care but allowed for separate and equal facilities that upon 
review were under resourced. The few hospitals that did allow Black patients did not 
allow Black physicians (Smith, 2015).   
The Hill-Burton Act and Title VI of the Civil Rights Act failed to define 
discrimination clearly (Smith, 2015).  While acts of overt discrimination such as giving 
privileges to physicians of color and admitting Black patients were clear, the more 
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insidious forms of discrimination, defined as disparate impact were less easily monitored 
or addressed (Smith, 2015).  Disparate impact can include the relocation of a health care 
facility from a poorer neighborhood to a more affluent neighborhood for business reasons 
or more subtle forms of disparate impact such as the United States having the lowest bed 
count to population ratio than any other country (Smith, 2015).  On its face, this policy 
appears neutral until you consider that a lower bed count means shorter hospital stays.  
Shorter hospital stays require patients to have the resources available in their 
neighborhood for adequate home care.  Lower income patients, typically Black and 
Hispanic patients, have less access to adequate home care than more affluent, typically 
White, patients do (Smith, 2015).   
Intrapersonal Discrimination: Lack of Culturally Competent Care 
Physician bias repeatedly has been shown to be inversely related to poor health 
outcomes a reflection of ineffective communication, treatment decisions, and biased 
perceptions (Chapman, Kaatz, & Carnes, 2013; Cooper et al., 2012; Sabin & Greenwald, 
2012; Staats & Patton, 2013; Zestcott, Blair, & Stone, 2016).  The studies, however, 
ignore structural and institutionalized racism as a factor in contributing to implicit and 
explicit biases.  This commonly accepted sociological approach misses the forest because 
it is too intently focused on the tree suggesting that an individual within a system can act 
independently of the system.  Notwithstanding the overwhelming evidence illustrating 
that adverse health outcomes are inversely correlated with physician bias, two notable 
studies suggested that physician bias has no meaningful impact on health outcomes (Blair 
et al., 2014; Penner, Blair, Albrecht, & Dovidio, 2014).  Their findings suggest that 
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physicians are capable of concurrently holding implicit biases while behaving explicitly 
as egalitarians. 
Unique Experience of Black Women 
Black women have a unique experience in the health care system.  Patients who 
are members of more than one social category experience intersectionality (Bowleg, 
2012).  Although it has been demonstrated that individual social groups experience 
adverse health outcomes resulting from racial bias in health care, few studies have 
examined how belonging to multiple social categories, such as being both Black and 
female, can affect health outcomes, (Bowleg, 2012; Hankivsky, 2012).  Originating in the 
Black feminist movement, intersectionality attempted to address how Black women fared 
differently in social institutions than being solely a woman or solely Black (Bowleg, 
2012).  Black women even with higher social achievement still do not fare as well as 
White women with equivalent social achievement, indicating that other factors are 
involved (Klassen, Pankiewicz, & Curriero, 2013; Klassen, Pankiewicz, Hsieh, Ward, & 
Curriero, 2015).  Black women are subjected to a two-fold health outcome setback due to 
a combination of two adverse characteristics subjected to both racial and sexual bias 
(Klassen et al., 2013; Klassen et al., 2015).   
Summary  
A racially biased social and political system has led to health care facilities that 
reflect institutional bias through medically underserved areas, structural discrimination 
through discriminatory policies and practices, and interpersonal discrimination through 
culturally incompetent care.  When social and political factors are compounded by 
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socioeconomics and tumor type, the result is disparate breast mortality outcomes between 
Black and White women.  Using data from the Georgia Center for Cancer Statistics and 
the American Hospital Association, in the proposed study I will examine the influence of 
selected characteristics of health care facilities on the disparate breast mortality outcomes 
between Black and White women.  The methods that will be used to answer the research 




Chapter 3: Methodology 
The purpose of this study was to determine whether selected characteristics of 
health care facilities can predict breast cancer survival rates.  Race was a proxy for 
culture, income was a proxy for poverty, and hospital ownership/control was a proxy for 
social justice factors.  Culture, poverty, and social justice were factors chosen from 
Freeman and Chu’s (2005) framework for social determinants of health inequalities for 
cancer.  The research questions for the study were designed to examine variables as 
predictors of breast cancer mortality rates and explain which variables exert significant 
influences.  Based on the criteria of the study, a quantitative research design was chosen.  
To examine the relationship between breast cancer survival and predictors of race, 
income, health care facility type, grade, and tumor type (four subvariables), the following 
analyses were performed: Kaplan-Meier method, log-rank tests, and Cox proportional 
hazards model (see Kleinbaum & Klein, 2012).    
This chapter includes a discussion of the quantitative methods related to research 
design, population demographics, sampling procedure, ethical considerations, research 
questions and hypotheses, data collection, the operationalization of variables, and 
description of data analysis used to address the research objectives. 
Research Design 
The approach in this study was quantitative with a retrospective cohort design, 
which was used to study whether the common exposure factors of health care facilities, 
income, and race are predictive of breast cancer survival outcomes between Black and 
White women.  The population, sampling procedure, ethics, study questions, data 
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collection, the operationalization of variables, and data analysis will be outlined in the 
following sections. 
Population 
The population for this study consisted of White women and Black women 
between the ages of 45 and 69 residing in the state of Georgia who were diagnosed with 
breast cancer between January 1, 2009, and December 31, 2014.  If there were two or 
more diagnoses of breast cancer (indicating relapse), only the initial diagnosis was used.  
Records were excluded if they were incomplete, such as missing relevant demographic or 
survival information.  This population was chosen because the incidence of breast cancer 
increases significantly in both Black and White women at the age of 45 and peaks at 69, 
with the median age being 65 (Howlader, Noone, & Krapcho, 2016).  The initial 
diagnosis was examined because a patient in relapse indicates a patient already in 
treatment versus a woman entering the health care system to be diagnosed.  Additionally, 
identification of stages at diagnosis helps to clarify when patients are being diagnosed. 
Data of 6,178 patients were provided. The following observations were removed 
from the analysis 
• Observations with unwanted categories for variables related to breast cancer 
survival (i.e., observations with responses = “4” for grade). 
• Observations with missing/unknown values for variables related to breast 
cancer survival, including  
o Responses = “9” for race and grade, 
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o Responses = “996” (Test ordered, results not interpretable), “997” (Test 
ordered, results not in chart), “998” (Test not done (not ordered or 
performed)), “988” (Not applicable: Information not collected for this 
case), and “999” (Unknown, no information provided) for the four 
variables for tumor type. 
The final data set contained 4,087 patients. 
Sampling and Sampling Procedures 
Records were extracted from the Georgia Cancer Registry based on defined 
criteria.  Criteria for inclusion were race (White, Black) gender (female) age (45-69), year 
of initial diagnosis (2009-20014), and cancer grades (I, II, III).  Additional criteria 
included diagnostic confirmation method (microscopically, positive laboratory 
test/marker study, direct visualization without microscopic confirmation, radiography 
without microscopic confirm, clinical diagnosis only), reporting source (hospital; 
radiation treatment center/medical oncology center, hospital affiliated; laboratory, 
hospital affiliated,;other hospital outpatient units/surgery centers), SEER summary stage 
2000 (in situ, localized, regional, distant site node), molecular subtype, census tract 
poverty indicator, marital status, cause of death, and treatment variables.  I restricted the 
analysis to only those cancers meeting the above criteria where a single hospital was 
involved in both the diagnosis and first course treatment of the cancer patient.  Finally, I 
linked registry records to an AHA Georgia hospital list using National Provider Identifier 




To access the data of the Georgia Cancer Registry, I completed an online form 
and submitted to the Georgia Department of Public Health.  This required initial contact 
with Emory University.  Emory University acts as the principal investigator for the 
Georgia Cancer Registry.  The process is to submit an initial application and study 
abstract to Emory University for review.  Included in the application is the requested data 
and data parameters.   
Ethical Considerations 
This study required approval from the Institutional Review Board (IRB) of 
Walden University.  An application was submitted for IRB approval before data 
collection. In addition to IRB approval from Walden University), IRB approval from the 
Georgia State Department of Public Health (approval no. 108609) was obtained to access 
the data stored in the Georgia Cancer Registry.   Additionally, I signed the registry’s Data 
Use Agreement to access and govern the use of the data.  Although there was no direct 
contact with human subjects, personal protected information patient data were used and 
therefore required IRB approval.   
Several measures were implemented to ensure the protection of human subjects.  
First, HIPAA protected data were stored in an encrypted laptop.  I used Bitlocker, which 
is a full disk encryption using AES encryption algorithm using a 256-bit key, to encrypt 
my entire laptop.  Second, per 45 CFR 164.528 I will retain records for a minimum of 6 
years.  After the required retention period stored data will be destroyed using Eraser, an 
advanced security tool for Windows that completely removes sensitive data from the hard 
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drive by overwriting it several times.  The laptop will then be taken to a county 
government facility for electronic hardware destruction.  I have been educated on HIPAA 
regulations and how to handle personal health information.  No identifiable information 
will be used in the dissertation.  No codes will be created that could link a subject to the 
data collected and recorded.  Any patient lists created will be destroyed at the earliest 
opportunity consistent with the conduct of the research.  I was the only one with access to 
the data.   
Research Questions and Hypothesis 
The central research question was: Do poverty, culture, and social justice affect 
the breast cancer survival rate of Black and White women in Georgia? The following are 
the research questions and hypotheses that guided the study? 
Research Question 1: Is poverty (income) a determinant of the breast cancer 
survival rate of Black and White women in Georgia? 
H01: Poverty is not a determinant of the breast cancer survival rate of Black 
and White women in Georgia. 
Ha1: Poverty is a determinant of the breast cancer survival rate of Black and 
White women in Georgia. 
Research Question 2: Is culture (race) a determinant of the breast cancer survival 
rate of Black and White women in Georgia? 
H02: Culture is not a determinant of the breast cancer survival rate of Black 
and White women in Georgia. 
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Ha2: Culture is a determinant of the breast cancer survival rate of Black and 
White women in Georgia. 
Research Question 3: Is social justice (a type of health care facility) a determinant 
of the breast cancer survival rate of Black and White women in Georgia? 
H03: Social justice is not a determinant of the breast cancer survival rate of 
Black and White women in Georgia. 
Ha3: Social justice is a determinant of the breast cancer survival rate of Black 
and White women in Georgia. 
Research Question 4: What is the relationship between poverty, culture, and 
social justice as a determinant of the breast cancer survival rate of Black and 
White women in Georgia? 
H04: None of the independent variables (poverty, culture, and social justice) 
have a statistically significant relationship on breast cancer survival rates of 
Black and White women in Georgia. 
Ha4: The independent variables (poverty, culture, and social justice) have a 
statistically significant relationship on breast cancer survival rates of Black 
and White women in Georgia. 
Data Collection 
This is a secondary data analysis.  Data were analyzed using SAS version 9.4 
(SAS Institute Inc., Cary, NC).  The data for this study will be collected from the Georgia 
Cancer Registry and the American Hospital Association.  The Georgia Cancer Registry is 
a cancer registry managed by Emory University.  The Georgia Cancer Registry contains 
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comprehensive population data on stage of cancer, patient survival, and patient 
demographics specific to the state of Georgia. 
Operationalization of Variables 
The following are the study variables and how they will be operationalized in the 
study.  
• Survival time (days): a continuous variable, computed as the difference between 
“date of last contact” and “date of diagnosis.” 
• Status: a categorical variable with two levels (1 (event or death) vs. 0 (censored))  
- According to the data set provided, the study time ended at 2018/02/19. Thus, 
(1) a patient did not experience the event (death) before the study ended, and (2) a 
person was lost to follow-up during the study period, were both considered 
“censored.”   
• Race: a categorical variable with two levels (Black vs. White) 
• Income: a categorical variable with 4 levels based on Census Track Poverty 
Indicator (1 = 0% - < 5% poverty, 2 = 5% - <10% poverty, 3 = 10% - <20% 
poverty, 4 = 20% - 100% poverty) 
• Health care facility type, a categorical variable with three levels (Nonprofit, for-
profit, and government) 
• Grade: a categorical variable with three levels (I, II, and III) 
• Tumor type: 4 variables were considered, including  
o Estrogen receptor (ER) assay (luminal A breast cancer), a categorical 
variable with two levels (ER positive vs. Not ER positive) 
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o Progesterone receptor (PR) assay (luminal B breast cancer), a categorical 
variable with two levels (PR positive vs. Not PR positive) 
o HER2 results (HER2 type breast cancer): a categorical variable with two 
levels (HER2 positive vs. Not HER2 positive) 
o Combinations of ER, PR, and HER2 results (triple-negative breast cancer), 
a categorical variable with two levels (Triple negative vs. Not triple 
negative) 
Data Analysis 
Data were analyzed using SAS version 9.4 (SAS Institute Inc., Cary, NC).  
Demographic profiles of each hospital type were summarized using frequency tables.  
To examine the relationship between breast cancer survival and predictors of 
interest, including race, income, health care facility type, grade, and tumor type (4 sub-
variables), the following analyses were performed, including, Kaplan-Meier method, log-
rank tests, and Cox proportional hazards model (Kleinbaum and Klein, 2012).  
For each predictor, without considering the effects of other predictors, Kaplan-
Meier method was used to estimate and graph the survival curves for different groups 
(ex: for race, there were two groups, Black and White). Log-rank tests were used to test if 
there was a statistically significant difference in the survival functions. For predictors 
with more than two categories, i.e., income, health care facility type, and grade, if the 
results of log-rank tests were significant, pairwise comparisons were performed to see 
which two categories had statistically significantly different survival curves. To control 
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for the family wise error rate, the multiple comparison procedure, the Tukey-Kramer 
method (Kramer, 1956), was implemented. 
A Cox, proportional hazards model, was implemented to determine the effect of 
each predictor on breast cancer survival after considering the effects of other predictors. 
Wald chi-square tests were used to determine if the effects of the predictors were 
significant. For predictors with more than two categories, i.e., income, health care facility 
type, and grade, if the results were significant, pairwise comparisons were performed to 
see which two categories had statistically significantly different survival curves. To 
control for the family wise error rate, the multiple comparison procedure, the Tukey-
Kramer method (Kramer, 1956), was implemented. Hazard ratios and the associated 95% 
confidence intervals were reported as a measure of the effect of each predictor. The 
proportional hazards assumption was examined using the graphical method of Lin, Wei, 
and Ying (1993) for checking the adequacy of the Cox, regression model. The 
assumption was satisfied. For all tests, a p-value less than 0.05 was considered 
significant.  
Threats to Validity 
Several primary variables of interest race and income are ascertained either 
through medical record or respondent survey; therefore, some self-reporting bias may 
exist.  However, the magnitude of the study should limit the impact of this bias.  Another 
important threat to validity is that the Georgia Cancer Registry does not report adjuvant 
therapies such as chemo-therapy and hormone therapy.  As stated in the literature review, 
both of these therapies should be offered to women with breast cancer per national 
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recommendations; therefore, inequitable access to these adjuvant therapies could 
potentially lead to disparate survival rates.  
Summary 
The purpose of Chapter 3 was to delineate the methodology of the study.  This 
chapter contains a description of the research design, target population, sampling and 
sampling procedures, ethical considerations, research questions and hypothesis, data 
collection, the operationalization of variables, data analysis, and threats to validity. 




Chapter 4: Results  
The purpose of this study was to determine breast cancer survival and race, 
income, health care facility type, grade, and tumor type.  I also examined the 
demographic profile of each health care facility type.  The current chapter will present the 
data and its analyses.  First, the chapter will include the study variables and the 
demographic variables collected from the Georgia Cancer Registry.  Then the data 
analysis methods will be presented before the data analysis results.  This analysis allowed 
for the examination of the impact of health facilities on breast cancer survival rates of 
Black and White women in Georgia.  
Data Collection 
The study variables related to breast cancer survival were as follows: 
• Survival time (days): a continuous variable, computed as the difference 
between “date of last contact” and “date of diagnosis.” 
• Status: a categorical variable with two levels (1 [event or death] and 0 
[censored])  
o According to the data set provided, the study time ended at 2018/02/19. 
Thus, (a) a patient did not experience the event (death) before the study 
ended, and (b) a person was lost to follow-up during the study period, 
were both considered “censored.”   
• Race: a categorical variable with two levels (Black and White) 
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• Income: a categorical variable with 4 levels based on Census Track Poverty 
Indicator (1 = 0% - < 5% poverty, 2 = 5% - <10% poverty, 3 = 10% - <20% 
poverty, 4 = 20% - 100% poverty 
• Health care facility type, a categorical variable with three levels (nonprofit, 
for-profit, and government) 
• Grade: a categorical variable with three levels (I, II, and III) 
• Tumor type: four variables were considered, including  
o Estrogen receptor (ER) assay (luminal A breast cancer), a categorical 
variable with two levels (ER positive vs. Not ER positive) 
o Progesterone receptor (PR) assay (luminal B breast cancer), a categorical 
variable with two levels (PR positive vs. Not PR positive) 
o HER2 results (HER2 type breast cancer): a categorical variable with two 
levels (HER2 positive vs. Not HER2 positive) 
o Combinations of ER, PR, and HER2 results (triple-negative breast cancer), 
a categorical variable with two levels (Triple negative vs. Not triple 
negative) 
The demographic variables of interest were as follows: 
• Personal demographics: martial status, race, age at diagnosis, income, and 
laterality 
• Grade: grade and diagnosis confirmation 
• Tumor type: luminal A breast cancer, luminal B breast cancer, HER2 type 
breast cancer, triple-negative breast cancer 
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• Treatment summary: type of surgery to the primary site performed, 
chemotherapy given as part of the first course of treatment, sequencing of 
radiation and surgery given as part of the first course of treatment, whether 
systemic hormonal agents were administered as first-course treatment at any 
facility, whether immunotherapeutic (biologic response modifiers) agents 
were administered as first course treatment at all facilities 
Methods 
Data were analyzed using SAS version 9.4.  Demographic profiles of each 
hospital type were summarized using frequency tables.  To examine the relationship 
between breast cancer survival and race, income, health care facility type, grade, and 
tumor type (four subvariables), the following analyses were performed: Kaplan-Meier 
method, log-rank tests, and Cox proportional hazards model (see Kleinbaum & Klein, 
2012). For each predictor, without considering the effects of other predictors, Kaplan-
Meier method was used to estimate and graph the survival curves for different groups 
(e.g., for race, there were two groups: Black and White).  Log-rank tests were used to test 
if there was a statistically significant difference in the survival functions.  For predictors 
with more than two categories (i.e., income, health care facility type, and grade) if the 
results of log-rank tests were significant, pairwise comparisons were performed to see 
which two categories had statistically significantly different survival curves.  To control 
for the family wise error rate, the multiple comparison procedure, the Tukey-Kramer 
method was implemented (see Kramer, 1956). 
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A Cox, proportional hazards model, was implemented to determine the effect of 
each predictor on breast cancer survival after considering the effects of other predictors. 
Wald chi-square tests were used to determine if the effects of the predictors were 
significant.  Hazard ratios and the associated 95% confidence intervals were reported as a 
measure of the effect of each predictor.  The proportional hazards assumption was 
examined using the graphical method of Lin, Wei, and Ying (1993) for checking the 
adequacy of the Cox, regression model.  The assumption was satisfied.  For all tests, a p-
value less than 0.05 was considered significant.  
Analysis Results 
Tables 1-4 present the demographic profiles of each hospital type.  Regarding 
personal demographics (Table 1), for each hospital type, over half of the patients were 
married (61.72% for for-profit, 55.12% for nonprofit, and 50.44% for government), a 
majority of the patients were White (73.42% for for-profit, 69.26% for nonprofit, and 
60.62% for government), and slightly under half of the patients were over 60 years-old 
(46.20% for for-profit, 45.90% for nonprofit, and 45.48% for government).  For for-profit 
hospitals, 39.56% of the patients were 10% - <20% poverty; for nonprofit hospitals, 
52.25% of the patients were 20%-100% poverty; and for government-run hospitals, 
40.72% of the patients were 20%-100% poverty.  Regarding laterality, over half of the 
patients were 1 for for-profit hospitals (52.22%) and 2 for nonprofit hospitals (53.89%) 
and government-run hospitals (52.54%).  
Regarding grade (Table 2), for each hospital type, the distributions of patients 
were almost equal among the three levels of tumor grade.  Almost all patients’ diagnosis 
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confirmation was based on positive histology (100% for for-profit, 99.80% for nonprofit, 
and 99.39% for government).    
Regarding tumor type (Table 3), regarding the test results of luminal A breast 
cancer, for each hospital, most of the patients were ER positive (83.54% for for-profit, 
78.69% for nonprofit, and 78.86% for government).  Regarding the test results of luminal 
B breast cancer, around 70% of the patients were PR positive (68.35% for for-profit, 
69.06% for nonprofit, and 67.93% for government).  Regarding the test results of HER2 
type breast cancer, over 80% of the patients were not HER2 positive (81.65% for for-
profit, 81.15% for nonprofit, and 82.24% for government).  Regarding test results of 
triple-negative breast cancer, approximately 10-15% of the patients were triple negative 
(10.76% for for-profit, 13.52% for nonprofit, and 14.74% for government). 
Regarding treatment summary (Table 4), for each hospital, over 90% of patients 
had surgery to the primary site performed (93.99% for for-profit, 95.08% for nonprofit, 
and 91.90% for government).  Regarding chemotherapy, over 60% of the patients in for-
profit hospitals (64.87%) were not given chemotherapy, whereas only around half of the 
patients in the nonprofit (48.77%) and government-run hospitals (53.55%) were not given 
chemotherapy.  A slightly higher percentage of patients in the for-profit hospitals were 
not given sequencing of radiation, in comparison to patients in the nonprofit and 
government-run hospitals (55.38% for for-profit, 44.06% for nonprofit, and 49.41% for 
government).  A slightly higher percentage of patients in the for-profit hospitals were not 
given systemic hormonal agents, in comparison to patients in the nonprofit and 
government-run hospitals (48.10% for for-profit, 36.89% for nonprofit, and 36.22% for 
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government).  A majority of the patients were not given immunotherapeutic agents 






Demographic Profiles (Personal Demographics) by Hospital Type 
  For-profit  
(N = 316) 
Nonprofit  
(N = 488) 
Government  
(N = 3283) 
Marital status Single 37 (11.71) 51 (10.45) 605 (18.43) 
 Married 195 (61.72) 269 (55.12) 1656 (50.44) 
 Separated 1 (0.32) 5 (1.02) 74 (2.25) 
 Divorced 48 (15.19) 81 (16.60) 527 (16.05) 
 Widowed 26 (8.23) 47 (9.63) 288 (8.77) 
 Unknown 8 (2.53) 35 (7.17) 129 (3.93) 
Race White 232 (73.42) 338 (69.26) 1990 (60.62) 
 Black 84 (26.58) 150 (30.74) 1293 (39.38) 
Age 45-49 40 (12.66) 72 (14.75) 495 (15.08) 
 50-54 63 (19.94) 86 (17.62) 581 (17.70) 
 55-59 67 (21.20) 106 (21.72) 714 (21.75) 
 60+ 146 (46.20) 224 (45.90) 1493 (45.48) 
Income 0% - <5% poverty 24 (7.59) 12 (2.46) 394 (12.00) 
 5% - <10% poverty 90 (28.48) 40 (8.20) 593 (18.06) 
 10% - <20% poverty 125 (39.56) 181 (37.09) 959 (29.21) 
 20% - 100% poverty 77 (24.37) 255 (52.25) 1337 (40.72) 
Laterality 1 165 (52.22) 224 (45.90) 1558 (47.46) 
 2 150 (47.47) 263 (53.89) 1725 (52.54) 
 4 1 (0.32) 0 0 







Demographic Profiles (Grade) by Hospital Type 
  For-profit  
(N = 316) 
Nonprofit  
(N = 488) 
Government  
(N = 3283) 
Grade I 75 (23.73) 117 (23.98) 743 (22.63) 
 II 122 (38.61) 173 (35.45) 1408 (42.89) 
 III 119 (37.66) 198 (40.57) 1132 (34.48) 
Diagnosis 
confirmation 
Positive histology 316 (100.0) 487 (99.80) 3263 (99.39) 
 Positive cytology, no 
positive histology 
0 0 20 (0.61) 
 Unknown whether or 
not microscopically 
confirmed 





Demographic Profiles (Tumor Type) by Hospital Type 
  For-profit  
(N = 316) 
Nonprofit  
(N = 488) 
Government  
(N = 3283) 
ER assay ER positive 264 (83.54) 384 (78.69) 2589 (78.86) 
 Not ER positive 52 (16.46) 104 (21.31) 694 (21.14) 
PR assay PR positive 216 (68.35) 151 (30.94) 1053 (32.07) 
 Not PR positive 100 (31.65) 337 (69.06) 2230 (67.93) 
HER2 results HER2 positive 58 (18.35) 92 (18.85) 583 (17.76) 
 Not HER2 
positive 
258 (81.65) 396 (81.15) 2700 (82.24) 
Combination of 
ER, PR, and HER2 
Triple negative 34 (10.76) 66 (13.52) 484 (14.74) 







Demographic Profiles (Treatment summary) by Hospital Type 
  For-profit  
(N = 316) 
Nonprofit  
(N = 488) 
Government  
(N = 3283) 
Surgery to the primary site 
performed 
No 19 (6.01) 24 (4.92) 266 (8.10) 
 Yes 297 (93.99) 464 (95.08) 3017 (91.90) 
 Unknown 0 0 0 
Chemotherapy No 205 (64.87) 238 (48.77) 1758 (53.55) 
 Yes 111 (35.13) 249 (51.02) 1518 (46.24) 
 Unknown 0 1 (0.2) 7 (0.21) 
Sequencing of radiation No 175 (55.38) 215 (44.06) 1622 (49.41) 
 Yes 141 (44.62) 273 (55.94) 1661 (50.59) 
 Unknown 0 0 0 
Systemic hormonal agents No 152 (48.10) 180 (36.89) 1189 (36.22) 
 Yes 155 (49.05) 286 (58.61) 1953 (59.49) 
 Unknown 9 (2.85) 22 (4.51) 141 (4.29) 
Immunotherapeutic agents No 298 (94.30) 449 (92.01) 3044 (92.72) 
 Yes 18 (5.70) 38 (7.79) 236 (7.19) 







Figure 1. Kaplan-Meier survival curves, by race. 
 
 




Figure 3. Kaplan-Meier survival curves, by health care facility type. 
 
 




Figure 5. Kaplan-Meier survival curves, by tumor type (ER assay). 
 
 





Figure 7. Kaplan-Meier survival curves, by tumor type (HER2). 
 
 





Figures 1-8 present the Kaplan-Meier survival curves, by race, income, health 
care facility, grade, and tumor types. The results of log-rank tests (Table 5) suggested that 
there was a statistically significant difference in the survival functions between White and 
Black (χ2(1) = 37.9244, p < 0.0001). The estimated 5-year survival probability was 
0.8648 for White and 0.7833 for Black.  
There was a statistically significant difference in the survival functions among 
patients with different income level (χ2(3) = 21.5580, p < 0.0001). The estimated 5-year 
survival probability was 0.8698 for 0-<5% poverty, 0.8731 for 5-<10% poverty, 0.8418 
for 10-<20% poverty, and 0.8020 for 20-100% poverty. The results of pairwise 
comparisons (Table 6) further suggested that there was a statistically significant 
difference in the survival functions between 0% - <5% poverty and 20% - 100% poverty 
(χ2(1) = 18.8820, p < 0.0001). There was a statistically significant difference in the 
survival functions between 10% - <20% poverty and 20% - 100% poverty (χ2(1) = 
10.8893, p < 0.0001). There was a statistically significant difference in the survival 
functions between 5% - <10% poverty and 20% - 100% poverty (χ2(1) = 17.9979, p < 
0.0001).  
There was no statistically significant difference in the survival functions among 
patients in different health care facilities (χ2(2) = 0.0150, p = 0.9926). There was a 
statistically significant difference in the survival functions among patients with different 
tumor grade (χ2(2) = 101.5461, p < 0.0001).  
The estimated 5-year survival probability was 0.9235 for tumor grade I, 0.8409 
for tumor grade II, and 0.7686 for tumor grade III. The results of pairwise comparisons 
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(Table 6) further suggested that there was a statistically significant difference in the 
survival functions between patients with tumor grade I and patients with tumor grade II 
(χ2(1) = 9.4944, p = 0.0058). There was a statistically significant difference in the 
survival functions between patients with tumor grade I and patients with tumor grade III 
(χ2(1) = 110.4, p < 0.0001). There was a statistically significant difference in the survival 
functions between patients with tumor grade IIII and patients with tumor grade II (χ2(1) = 
39.5249, p < 0.0001).  
There was a statistically significant difference in the survival functions between 
patients who were ER positive and patients who were not ER positive (χ2(1) = 70.9905, p 
< 0.0001). The estimated 5-year survival probability was 0.8588 for patients who were 
ER positive and 0.7392 for patients who were not ER positive. There was a statistically 
significant difference in the survival functions between patients who were PR positive 
and patients who were not PR positive (χ2(1) = 84.1358, p < 0.0001). The estimated 5-
year survival probability was 0.8712 for patients who were PR positive and 0.7549 for 
patients who were not PR positive. There was a statistically significant difference in the 
survival functions between patients who were HER2 positive and patients who were not 
HER2 positive (χ2(1) = 4.8464, p = 0.0277). The estimated 5-year survival probability 
was 0.8081 for patients who were HER2 positive and 0.8394 for patients who were not 
HER2 positive. There was a statistically significant difference in the survival functions 
between patients who were triple negative and patients who were not triple negative 
(χ2(1) = 72.5394, p < 0.0001). The estimated 5-year survival probability was 0.7136 for 





Results of Log-Rank Tests 
   Results of log-rank test 
  5-year (1825 days) 
survival probability 
χ2 DF p 
Race White 0.8648 37.9244 1 < 0.0001* 
 Black 0.7833    
Income 0% - <5% 
poverty 
0.8698 21.5580 3 < 0.0001* 
 5% - <10% 
poverty 
0.8731    
 10% - <20% 
poverty 
0.8418    
 20% - 100% 
poverty 
0.8020    
Facility Nonprofit 0.8333 0.0150 2 0.9926 
 For-profit 0.8540    
 Government 0.8207    
Grade I 0.9235 101.5461 2 < 0.0001* 
 II 0.8409    
 III 0.7686    
Tumor type (ER 
assay) 
ER positive 0.8588 70.9905 1 < 0.0001* 
 Not ER positive 0.7392    
Tumor type (PR 
assay) 
PR positive 0.8712 84.1358 1 < 0.0001* 
 Not PR positive 0.7549    
Tumor type 
(HER2 assay) 
HER2 positive 0.8081 4.8464 1 0.0277* 
 Not HER2 
positive 
0.8394    
Tumor type 
(triple negative) 
Triple negative 0.7136 72.5394 1 < 0.0001* 
 Not triple 
negative 
0.8547    






Results of Pairwise Comparisons 
 Pairwise comparison χ2 DF p 
Income 0% - <5% poverty vs. 10% - <20% poverty 0.0059 1 0.9998 
 0% - <5% poverty vs. 20% - 100% poverty 18.8820 1 < 
0.0001* 
 0% - <5% poverty vs. 5% - <10% poverty 0.2765 1 0.9529 
 10% - <20% poverty vs. 20% - 100% 
poverty 
10.8893 1 0.0053* 
 10% - <20% poverty vs. 5% - <10% poverty 0.2237 1 0.9650 
 20% - 100% poverty vs. 5% - <10% poverty 17.9979 1 < 
0.0001* 
Grade I vs. II  9.4944 1 0.0058* 
 I vs. III 110.4 1 < 
0.0001* 
 II vs. III 39.5249 1 < 
0.0001* 
Note. * indicates significance at the 0.05 level. 
 
The results of the Cox proportional odds model are displayed in Table 7 and 8. The 
analysis results of the Cox model indicated that  
• There was a statistically significant relationship between breast cancer survival 
and race, after controlling for other predictors (χ2(1) = 8.0432, p = 0.0046; Table 
7). In particular, the hazard of death for Black was 1.2703 times of the hazard for 
White (Hazard ratio = 1.2703, 95% CI = 1.0767, 1.4987; Table 8). 
• There was no statistically significant relationship between breast cancer survival 




• There was no statistically significant relationship between breast cancer survival 
and health care facility type, after controlling for other predictors (χ2(2) = 0.3647, 
p = 0.8333; Table 7). 
• There was a statistically significant relationship between breast cancer survival 
and tumor grade, after controlling for other predictors (χ2(2) = 43.6036, p < 
0.0001; Table 7). In particular, the hazard of death for patients with grade I tumor 
was 0.4442 times of the hazard for patients with grade II tumor (Hazard ratio = 
0.4442, 95% CI = 0.3205, 0.6155); the hazard of death for patients with grade I 
tumor was 0.3797 times of the hazard for patients with grade III tumor (Hazard 
ratio = 0.3797, 95% CI = 0.2680, 0.5380; Table 8). 
• There was no statistically significant relationship between breast cancer survival 
and tumor type (ER assay), after controlling for other predictors (χ2(1) = 0.5658, p 
= 0.4520; Table 7). 
• There was a statistically significant relationship between breast cancer survival 
and tumor type (PR assay), after controlling for other predictors (χ2(1) = 8.1559, p 
= 0.0043; Table 7). In particular, the hazard of death for patients who were PR 
positive was 1.3858 times of the hazard for patients who were not PR positive 
(Hazard ratio = 1.3858, 95% CI = 1.1078, 1.7337; Table 8). 
• There was no statistically significant relationship between breast cancer survival 
and tumor type (HER2 assay), after controlling for other predictors (χ2(1) = 
0.2073, p = 0.6489; Table 7). 
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• There was no statistically significant relationship between breast cancer survival 
and tumor type (triple negative), after controlling for other predictors (χ2(1) = 
3.0748, p = 0.0795; Table 7). 
Table 7 
 
Testing Results of the Cox Model 
Variable DF Wald chi-square p 
Race 1 8.0432 0.0046* 
Income 3 7.0416 0.0706 
Facility 2 0.3647 0.8333 
Grade 2 43.6036 < 0.0001* 
Tumor type (ER assay) 1 0.5658 0.4520 
Tumor type (PR assay) 1 8.1559 0.0043* 
Tumor type (HER2 assay) 1 0.2073 0.6489 
Tumor type (triple 
negative) 
1 3.0748 0.0795 







Variable Category Reference category Hazard ratio 95% CI 
Race Black White 1.2703 (1.0767, 1.4987)* 
Income 0% - <5% poverty  10% - <20% poverty 0.9689 (0.6472, 1.4505) 
 0% - <5% poverty  20% - 100% poverty 0.8010 (0.5395, 1.1891) 
 0% - <5% poverty  5% - <10% poverty 1.0381 (0.6692, 1.6106) 
 10% - <20% poverty 20% - 100% poverty 0.8267 (0.6511, 1.0496) 
 10% - <20% poverty 5% - <10% poverty 1.0714 (0.7745, 1.4822) 
 20% - 100% poverty 5% - <10% poverty 1.2961 (0.9487, 1.7705) 
Facility For-profit Government 1.0613 (0.7454, 1.5110) 
 For-profit Nonprofit 1.0891 (0.8185, 1.4492) 
 Government Nonprofit 1.0262 (0.8062, 1.3063) 
Grade I II 0.4442 (0.3205, 0.6155)* 
 I III 0.3797 (0.2680, 0.5380)* 
 II III 0.8548 (0.6876, 1.0627) 
Tumor type 
(ER assay) 
ER positive Not ER positive 1.1411 (0.8090, 1.6097) 
Tumor type 
(PR assay) 








Triple negative Not triple negative 0.7090 (0.4827, 1.0413) 
Note. CI = confidence interval. 95% CI was adjusted by the Tukey-Kramer method. * 




The Cox proportional odds model assumes that the hazard ratio comparing any 
two specifications of predictors is constant over time (Kleinbaum and Klein, 2012). The 
proportional hazards assumption was examined using the graphical method of Lin, Wei, 
and Ying (1993) for checking the adequacy of the Cox regression model.  
For each covariate, a graphical display of the empirical score process was created, 
which is based on the martingale residuals. Figures 9-20 display the graphs for the 
covariates in the Cox model. For each figure, the solid line is the observed empirical 
score process. The dashed lines are empirical score processes based on 20 random 
simulations that embody the proportional hazards assumption. If the observed process 
deviates markedly from the simulated processes, it is evidence against the proportional 
hazards assumption. Among the 12 figures, the observed process for, Facility 
(government vs. nonprofit; Figure 14), Grade (II vs. III; Figure 16), Tumor type (ER 
assay (ER positive vs. not ER positive; Figure 17), Tumor type (PR assay (PR positive 
vs. not PR positive; Figure 18), and Tumor type (triple negative (triple negative vs. not 
triple negative; Figure 20), was more extreme than the simulated processes. However, as 
recommended by Kleinbaum and Klein (2012), one should use a conservative strategy for 
this decision by assuming the proportional odds assumption is satisfied unless there is 
strong evidence of nonparallelism of observed and simulated processes are strongly 
discrepant. Therefore, using a conservative strategy, we concluded that the proportional 





Figure 9. Race (Black vs. White). 
 
 





Figure 11. Income (10%-<20% poverty vs. 5% - <10% poverty). 
 
 





Figure 13. Facility (for-profit vs. nonprofit). 
 
 





Figure 15. Grade (I vs. III). 
 
 




Figure 17. Tumor type (ER assay [ER positive vs. not ER positive]). 
 
 





Figure 19. Tumor type (HER2 assay [HER2 positive vs. not HER2 positive]). 
 
 




Black women continue to suffer increased mortality compared to White woman, 
despite socioeconomic interventions.  Chapter 4 presented the results of the study.  The 
results showed that there is no statistically significant difference in the survival function 
among patients in different health care facilities.  The results did confirm previously 
published correlations between race, income, and tumor grade.  Chapter 5 interprets the 




Chapter 5: Summary, Conclusion, and Recommendations  
Moya Zakia Bailey (2013) in her graduate thesis coined the term Misogynor.  She 
used the term to refer to the intersectionality of sex and race of Black women:   
Misogynoir is a term I created during my exams to express the specific ways in 
which Black women (cis and trans) are targeted within popular culture. The term 
is a combination of misogyny, the hatred of women and noir, which means black 
but also carries film and media connotations. It is the particular amalgamation of 
anti-black racism and misogyny in popular media and culture that targets black 
trans and cis women. (p. 26) 
Although the term misogynoir was used by Bailey to discuss how Black woman are 
negatively targeted by media, the term is appropriate in other settings where Black 
women suffer adverse consequences resulting from a combined bias against their gender 
and race—for example, Serena Williams’s health concerns being dismissed (Salam, 
2018).  In relation to the current study, Black women with breast cancer report having to 
advocate to obtain information regarding treatment-related symptoms and treatment risks 
as well as for medication to treat symptoms (Samuel et al., 2018).  Additionally, Black 
women are more likely to chemotherapy delays, which further delays surgery (Yung, 
2018).  Although evidence suggests that structural and systemic racism plays a role in 
negative health outcomes from Black women, the present study did not reveal a 





The purpose of this study was to determine whether poverty, culture, and social 
justice affect the breast cancer survival rate of Black and White women in Georgia.  To 
consider this question, the theoretical concepts of poverty, culture, and social justice were 
operationalized using proxy variables that could be measured.  Income was used as a 
proxy for poverty and operationalized as a categorical variable with four levels based on 
the Census Track Poverty Indicator (1 = 0% - < 5% poverty, 2 = 5% - <10% poverty, 3 = 
10% - <20% poverty, 4 = 20% - 100% poverty).  Race was used as a proxy for culture 
and operationalized as a categorical variable with two levels (Black and White).  Health 
care facility type was used as a proxy for social justice and operationalized as a 
categorical variable with three levels (nonprofit, for-profit, and government).  Tumor type 
and grade was also considered in recognition that health care facilities are not able to 
control the health status of patients entering their facility. 
Research Question 1 
Research Question 1: Is poverty (income) a determinant of the breast cancer 
survival rate of Black and White women in Georgia? 
H01: Poverty is not a determinant of the breast cancer survival rate of Black 
and White women in Georgia. 
Ha1: Poverty is a determinant of the breast cancer survival rate of Black and 
White women in Georgia. 
The results suggested that survival functions among patients with different income 
levels were statistically significant.  The Census Tract Poverty Indicator in relation to the 
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Georgia Cancer Registry indicates the level of poverty in the patient’s area at the time of 
diagnosis.  A woman with breast cancer in a census tract with 0-<5% poverty (0.8698) 
has a slightly higher 5-year survival probability than a woman with breast cancer in a 
census tract with 20-100% poverty (0.8020).  When levels of poverty were compared 
there was a statistically significant difference in the survival function between the lower 
percentages of poverty and higher percentages of poverty.  The findings suggest that 
women with breast cancer in areas of increased poverty will have significantly poorer 
health outcomes than woman in areas of low poverty.   
These findings confirm Freeman and Chu’s (2005) view that poverty has a 
significant impact on incidence, access, and treatment.  Lack of health insurance, being 
underinsured, poor diet, exposure to toxic environments, and the lack of information and 
education related to health influence health seeking behaviors as well as compliance.  
These factors can result in delayed treatment of a more advanced stage of breast cancer.  
The Freeman and Chu model of social determinants of cancer also suggests that health 
care providers may not be as competent or lack board-certification, resulting in failure to 
adhere to recommended treatment guidelines. 
Research Question 2 
Research Question 2: Is culture (race) a determinant of the breast cancer survival 
rate of Black and White women in Georgia? 
H02: Culture is not a determinant of the breast cancer survival rate of Black 
and White women in Georgia. 
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Ha2: Culture is a determinant of the breast cancer survival rate of Black and 
White women in Georgia. 
There was a statistically significant difference in the survival function between 
White and Black women with breast cancer.  The 5-year survival probability of White 
women with breast cancer as 0.8648 and 0.7833 for Black women with breast cancer.  
Therefore, race is a significant determinant of breast cancer survival probability. 
Although Freeman and Chu (2005) acknowledged that race and culture are not 
always synonymous, in health care settings race is often used as both a proxy for culture 
and poverty.  According to Freeman and Chu, culture can act as a way to interpret 
information and respond to diagnosis.  Culture can also influence health related behaviors 
such as drinking, smoking, and diet.    
Research Question 3 
Research Question 3: Is social justice (type of health care facility) a determinant 
of the breast cancer survival rate of Black and White women in Georgia? 
H03: Social justice is not a determinant of the breast cancer survival rate of 
Black and White women in Georgia. 
Ha3: Social justice is a determinant of the breast cancer survival rate of Black 
and White women in Georgia. 
There was no statistically significant difference in the survival function of patients 
in different health care facilities.  Freeman and Chu (2005) viewed social justice in terms 
of racism, discrimination, and bias.  They recognized that this type of social (in)justice 
can influence everything from screening to treatment.  The report “Unequal Treatment: 
75 
 
Confronting Racial and Ethnic Disparities in Health Care” by The Institute of Medicine 
showed evidence of racial bias along the spectrum of cancer care.  Whether conscious or 
implicit, providers were shown to adhere to standards of care (Nelson, 2002). 
Research Question 4 
Research Question 4: What is the relationship between poverty, culture, and 
social justice as a determinant of the breast cancer survival rate of Black and 
White women in Georgia? 
H04: None of the independent variables (poverty, culture, and social justice) 
have a statistically significant relationship on breast cancer survival rates of 
Black and White women in Georgia. 
Ha4: The independent variables (poverty, culture, and social justice) have a 
statistically significant relationship on breast cancer survival rates of Black 
and White women in Georgia. 
When breast cancer survival was compared to race there was a statistically 
significant relationship.  The hazard of death for a Black woman with breast cancer was 
1,270 times the hazard if White women.  However, there was no statistically significant 
relationship between breast cancer survival and income or health care facility.  There was 
a statistically significant relationship between breast cancer and tumor grade. 
Specifically, the hazard of death for patients with grade I tumor was 0.4442 times of the 
hazard for patients with grade II tumor and the hazard of death for patients with grade I 
tumor was 0.3797 times of the hazard for patients with grade III tumor.  This may suggest 




The data used to analyze the research questions will be collected from the Georgia 
Cancer Registry which collects data for one state and the American Hospital Association.  
Therefore, the findings cannot be generalized nationally.  Additionally, the quantitative 
results of the study can only demonstrate correlation and not causation. 
This study was limited to the study of health care facilities in Georgia and to 
Black and White women in Georgia diagnosed with breast cancer.  The study will 
analyzed only data downloaded from Georgia Cancer Registry and the American 
Hospital Association. This study sought to determine if there is a correlation between the 
stated variables.  The study did not determine the causal nature of any identified 
relationship.  It provided preliminary data that can serve as a foundation for further 
research that can elucidate causal relationships.   
The study was also limited by the cost of the data.  Hospital data is considered 
proprietary and therefore is sold to researchers.  The limited database I was able to 
purchase cost several hundred dollars.  The addition of additional variables of interest 
such as insurance types accepted, training facility, breast cancer technology available 
would have resulted in a database that cost thousands rather than hundreds of dollars.   
A further limitation is that Georgia State does not encourage data analysis of 
specific hospitals, therefore all analysis was limited to health care facility type.  A 
supplementary analysis of how the type of breast cancer screening services and 
treatments offered could potential influence on survival probability was limited by the 




The findings of the study suggest that health care facility type as defined by 
control/ownership type does not influence breast cancer survival rates in the state of 
Georgia.  However, as discussed in the literature review, previous studies have 
demonstrated racial bias by physicians and perceived racial bias by Black patients.  Given 
the well-documented history of institutionalized racism within the health care system 
towards Black patients, the results were unexpected but not surprising considering the 
unwillingness of both hospitals and the State of Georgia to permit a resource detailed, 
hospital-specific study of racial bias related to breast cancer survival outcomes. 
The first recommendation would be to expand the hospital variables to include 
factors such as bed size, rural/urban, teaching status, community partnerships, patient 
population, cancer services/technology available, payment types, and hospital 
demographics.  The above variables could provide additional insight into the availability 
of services available in different types of communities as well as the training and more 
specifically the availability of well-trained physicians.   
The second recommendation is to expand the size of the study.  This study only 
included data for a single state, Georgia, so the results cannot be generalized.  Data 
should be gathered from the Surveillance, Epidemiology, and End Results database with 
a national sample and aligned with the American Hospital Association data on hospitals.  
The health disparity of breast cancer survival rates between Black and White women is 
nationwide.  For results that are meaningful, the sample should be drawn nationally. 
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A third recommendation is a mixed methods study as a prospective cohort.  
Although a quantitative study can demonstrate correlation, it cannot illustrate causation.  
The study was a quantitative study and therefore is limited to correlations of data, a 
quantitative study will not explain the why.  Quantitative finding coupled with findings 
from qualitative interviews of both patients and physicians and reviews of records may 
help to guide the understanding of racial disparities in breast cancer survival rates. 
Implications 
At the core of this study is the question, what is the best option for care for a 
woman with breast cancer, particularly Black women with demonstrated higher mortality 
rates.  This is socially significant because if the survival probability can increase based on 
where they are getting care, then there are actions that can be taken that can improve care 
for all breast cancer patients.  For example, if Black women were to have better outcomes 
in government owned and controlled hospitals, further research could determine the best 
practices for improved survival for all patients, not just Black women.   
A study of this type can also have policy implications.  If hospital type influences 
breast cancer mortality rate, do we need to examine the way insurance handles referrals.  
Should referrals be based on race, tumor, grade and hospital type?  Do we use this 
information to justify how health insurance is allocated?  How resources are allocated.   
Conclusion  
The study results suggest that there is no relationship between healthcare facility 
type and breast cancer survival probability.  This result was unexpected given the number 
of studies illustrating racial disparities in treatment.  This may imply that all hospital 
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types perform poorly in the treatment of Black women and therefore the problem is 
systemic and needs to be examined using a different method.  Another implication may 
be that given the disparate mortality rates for Black women there may be a need to 
differentiate the treatment protocol to specifically address the health needs of Black 
women. 
It is interesting to note the even though Black women experience poorer breast 
cancer survival rates when compared to their peers, there has not been a corresponding 
uptick in breast cancer awareness programs that specifically target Black women.  Most 
breast cancer awareness programs are noticeably race neutral.  The studies have been 
conducted demonstrating the health disparity of breast cancer survival rates, the studies 
have been conducted demonstrating that Black women are more frequently diagnosed 
with triple negative breast cancer, which is the worst type of breast cancer, yet most 
breast cancer programs remain race neutral, along with screening recommendations, and 
insurance handling of referrals.   
Although the results of this study did not suggest that health care facility type 
influence breast cancer survival rates, perhaps the failure to demonstrate any correlation 
is the most damaging evidence of institution racial bias.  Given the plethora of evidence-
based information revealing a race-based health disparity, health care facilities should be 
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